POPULAR SEARCHES
betadine-antiseptic-solution-pvpi-10

BETADINE® Antiseptic Solution PVP-I 10%

MINOR CUTS WOUNDS ABRASIONS BURNS
  • Kills germs quickly to prevent infections in minor cuts, wounds, abrasions and burns.
  • Indicated for degerming skin, wounds and mucous membrane in:
    • Preoperative preparation of skin and mucus membranes.
    • Post operative surgical wound infection.
    • Casualty procedures, including prevention of infection in burns, lacerations and abrasions. Treatment of various bacterial, viral, protozoal and mycotic skin infections, including tinea, herpes simplex and zoster infections.
    • For hygienic and surgical disinfection of the hands.
PRESCRIBING INFORMATION

How to use?

betadine-antiseptic-ointment-step-1

1

Spread the BETADINE®
Antiseptic Solution, undiluted,
onto the parts to be treated. After
drying, an air-permeable film is
formed, which can be easily
washed off with water1

betadine-antiseptic-ointment-step-3

2

The solution can be applied
several times per day.1

RELATED PRODUCTS

LEARN MORE
betadine-dry-powder-spray

BETADINE® Dry Powder Spray PVP-I 2.5%

LEARN MORE
betabetadine-antiseptic-ointment-pvpi-10-with-box

BETADINE® Antiseptic Ointment PVP-I 10%

WHERE TO BUY

Shop online

Shop products online

Shop in store

Locate a partner store near you

REFERENCES

  1. BETADINE®  Antiseptic Solution insert leaflet
  2. Lachapelle J et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. 2013; 10(5): 579-592.
  3. Mayer DA, et al. Povidone-Iodine and wound healing: A Critical Review. Wounds: A Compendium of Clinical Research and Practice. 1993; 5(1): 14-23.
  4. Remington "The Science & Practice of Pharmacy" 20th Ed, William K.Nichols, PhD. Anti-Infectives. Chapter 87-1516
  5. Fleischer W, Reimer K. Povidone Iodine: in antisepsis-State of Art. Dermatology 1997;195 (suppl 2):3-9
  6. Reimer K, Schreier H, Erdos G, Konig W, Fleischer W. Molecular effects of a microbicidal substance on relevant microorganisms: electron microscopic and biochemical studies on Povidone-iodine.  Zentralbi Hyg Umweltmed. 1998 Feb; 200(5-6):423-34.
  7. Russel, AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrobiol Chemo (2003) 52, 750-763.
  8. Rutala W, Weber D. The Healthcare Infection Control Practices Advisory Committee (HICPAC)
  9. Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev. Jan. 1999. 147-179.
  10. Eming SA, et al. A novel property of povidone-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J In Dermatol (2006) 126, 2731-2733.
  11. Kunisada T,Yamada K, Oda S and Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 1997; 195(suppl 2): 14-18.
  12. Lachapelle J, Castel O, et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. (2013) 10(5), 579-592.
  13. Hand, Foot and Mouth Disease Information Sheet. World Health Organization (Western Pacific Region). Available at http://www.wpro.who.int/emerging_diseases/hfmd.information.sheet/en. Accessed on 29/11/2016.
  14. Leyden J., Stewart R., et al. Updated in vivo Methods for Evaluating Topical Antimicrobial Agents on Human Skin. The Journal of Investigative Dermatology, Vol 72(4): 165-170, 1979

CONTRAINDICATIONS

  • BETADINE® Antiseptic Solution is contraindicated for patients with hypersensitivity to iodine, hyperthyroidism.
  • Not to be used in children under 2 years of age.
  • During pregnancy and lactation, BETADINE® Antiseptic Solution should only be used if strictly prescribed by a doctor and its use should be kept to an absolute minimum.

Please report any suspected Mundipharma Product or Device related adverse event or product complaint to: meadrugsafety@mundipharma.ae or contact +971 4 439 8777.

Consult your doctor / pharmacist before taking pharmaceutical products